薛欠欠, 陈长浩, 李方梅, 于秀梅, 司肖肖, 杨燕. 团体生物反馈法对残留型精神分裂症患者的疗效[J]. 实用临床医药杂志, 2023, 27(22): 95-99. DOI: 10.7619/jcmp.20231836
引用本文: 薛欠欠, 陈长浩, 李方梅, 于秀梅, 司肖肖, 杨燕. 团体生物反馈法对残留型精神分裂症患者的疗效[J]. 实用临床医药杂志, 2023, 27(22): 95-99. DOI: 10.7619/jcmp.20231836
XUE Qianqian, CHEN Changhao, LI Fangmei, YU Xiumei, SI Xiaoxiao, YANG Yan. Efficacy of group biofeedback in patients with residual schizophrenia[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 95-99. DOI: 10.7619/jcmp.20231836
Citation: XUE Qianqian, CHEN Changhao, LI Fangmei, YU Xiumei, SI Xiaoxiao, YANG Yan. Efficacy of group biofeedback in patients with residual schizophrenia[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 95-99. DOI: 10.7619/jcmp.20231836

团体生物反馈法对残留型精神分裂症患者的疗效

Efficacy of group biofeedback in patients with residual schizophrenia

  • 摘要:
    目的 观察团体生物反馈法对残留型精神分裂症(RS)患者的疗效。
    方法 选取RS患者127例为研究对象,随机分为对照组(n=63)和观察组(n=64)。对照组采用常规护理,观察组在对照组基础上实施团体生物反馈法。比较2组患者阳性和阴性症状量表(PANSS)、个人和社会功能量表(PSP)评分以及自知力问卷(SAI)评分(治疗依从性)。
    结果 干预12周后,观察组阳性症状、阴性症状评分及PANSS总分低于对照组,差异有统计学意义(P<0.05)。干预后,观察组PSP得分为>70~100分、>30~70分的患者例数多于对照组,0~30分的患者例数少于对照组,差异有统计学意义(P<0.05)。干预后,观察组SAI评分高于干预前和对照组,观察组完成生物反馈疗法次数多于对照组,差异有统计学意义(P<0.05)。
    结论 团体生物反馈法可促进RS患者症状缓解,提高其治疗依从性。

     

    Abstract:
    Objective To observe the effect of group biofeedback in patients with residual schizophrenia (RS).
    Methods A total of 127 patients with RS were selected as study objects, and randomly divided into control group (n=63) and observation group (n=64). The control group received routine nursing, and the observation group received group biofeedback based on the control group. The Positive and Negative Symptom Scale (PANSS), Personal and Social Performance Scale (PSP) and Self-awareness Inventory (SAI) Questionnaire (treatment compliance) scores were compared between the two groups.
    Results After 12 weeks of intervention, the score of the positive symptoms, the score of negative symptoms and the total score of PANSS in the observation group were significantly lower than those in the control group (P < 0.05). The number of patients with PSP scores greater than 70 to 100 and greater than 30 to 70 in the observation group was significantly more than those in the control group, and the number of patients with PSP score of 0 to 30 was significantly less than that in the control group (P < 0.05). The SAI score of the observation group after intervention was significantly higher than that before intervention and control group, and the number of completed biofeedback therapy in the observation group was significantly more than that in the control group (P < 0.05).
    Conclusion Group biofeedback can promote symptom relief and improve treatment compliance in patients with RS.

     

/

返回文章
返回